Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
02 juin 2023 16h00 HE
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., June 02, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on May 31, 2023 it granted stock options to purchase an aggregate of...
AquaBounty Announces a Pause to Ohio Farm Construction While It Evaluates Scope Alternatives and a Possible Phased Approach
02 juin 2023 08h00 HE
|
AquaBounty Technologies, Inc.
MAYNARD, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance...
Bluejay Therapeutics Advances in Hepatitis B and D Trials: Successfully Completes BJT-778 Phase 1a Study and Begins Phase 1b Trial Enrollment
01 juin 2023 18h14 HE
|
Bluejay Therapeutics
SAN MATEO, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a company dedicated to developing innovative treatments for viral and liver diseases, announces the successful completion...
Cytokinetics to Participate in Upcoming Investor Conferences
01 juin 2023 16h00 HE
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor...
Recursion to Participate in Upcoming Investor Conferences
01 juin 2023 08h30 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in...
Madrigal Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences
01 juin 2023 08h00 HE
|
Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., June 01, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic...
ADC Therapeutics to Participate in the Jefferies Healthcare Conference
01 juin 2023 07h15 HE
|
ADC Therapeutics SA
LAUSANNE, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the...
Jnana Therapeutics to Present at the Jefferies Healthcare Conference
01 juin 2023 07h00 HE
|
Jnana Therapeutics, Inc.
BOSTON, June 01, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets,...
atai Life Sciences to Participate in Upcoming June Investor Conferences
01 juin 2023 06h59 HE
|
atai Life Sciences
NEW YORK and BERLIN, June 01, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health...
BC Platforms Acquires 4Pharma, a Leading International Provider of Medical Research Data and Analytics Services for Global Clinical Trials and Real World Data
01 juin 2023 03h00 HE
|
BC Platforms
ZURICH, Switzerland, June 01, 2023 (GLOBE NEWSWIRE) -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the acquisition of 4Pharma Ltd, a...